Exploration and Preparation of a Dose-Flexible Regulation System for Levetiracetam Tablets via Novel Semi-Solid Extrusion Three-Dimensional Printing

被引:53
作者
Cui, Mengsuo [1 ]
Li, Yuenan [1 ]
Wang, Shu [1 ]
Chai, Yuanyuan [1 ]
Lou, Jintong [1 ]
Chen, Fen [2 ,3 ]
Li, Qijun [1 ]
Pan, Weisan [1 ]
Ding, Pingtian [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, Dept Pharmaceut, 103 Wenhua Rd, Shenyang 110016, Peoples R China
[2] Liaoning Univ Tradit Chinese Med, Key Lab, Minist Educ TCM Viscera State Theory & Applicat, 79 Chongshan East Rd, Shenyang 110847, Liaoning, Peoples R China
[3] Zhejiang Jingxin Pharmaceut Co Ltd, 800 Xinchang Ave East,Yulin St, Xinchang 312500, Peoples R China
关键词
semi-solid extrusion 3D printing; levetiracetam; dose-flexible regulation system; individual-tailored medicines; linear correlation; patterns; mechanical properties; dissolution behavior; 3D; RELEASE; CHILDREN; IMMEDIATE;
D O I
10.1016/j.xphs.2018.10.001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Levetiracetam therapy is often associated with high levels of individual variation in the recommended dose required to achieve preferential treatment. Thus, a reliable and dynamic regulation system to accurately tailor dose is necessary. The main objective of this study is to explore and prepare a dose-flexible control system suitable for rapid release tablets equipped with high drug loading and a cylindrical model design. Semi-solid extrusion 3-dimensional printing was utilized to fabricate a series of tablets of increased volume. This method was compatible with 3 patterns to regulate the volumes to manipulate the tablet mass and achieve tailored personalized precision dosing. All tablets from each pattern exhibited a smooth surface and regular shape, as well as sufficient mechanical strength. A good linear correlation between the mass and theoretical volume of the tablets was maintained, regardless of the pattern used. The range of dose accuracy was between 103.3% and 96.2%, with an acceptable variation coefficient in the range of 0.6%-3.2%. Faster release behavior for levetiracetam can be achieved from the small-sized tablets due to their larger surface area/mass ratio. All the results demonstrated the potential and capability of semi-solid extrusion 3-dimensional printing as a novel pharmaceutical manufacturing technique to provide a dynamic and highly accurate controllable system for preparing patient-tailored medicines. (c) 2019 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:977 / 986
页数:10
相关论文
共 37 条
[1]   Emergence of 3D Printed Dosage Forms: Opportunities and Challenges [J].
Alhnan, Mohamed A. ;
Okwuosa, Tochukwu C. ;
Sadia, Muzna ;
Wan, Ka-Wai ;
Ahmed, Waqar ;
Arafat, Basel .
PHARMACEUTICAL RESEARCH, 2016, 33 (08) :1817-1832
[2]   Personalised dosing: Printing a dose of one's own medicine [J].
Alomari, Mustafa ;
Mohamed, Fatima H. ;
Basit, Abdul W. ;
Gaisford, Simon .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 494 (02) :568-577
[3]   Tailored on demand anti-coagulant dosing: An in vitro and in vivo evaluation of 3D printed purpose-designed oral dosage forms [J].
Arafat, Basel ;
Qinna, Nidal ;
Cieszynska, Milena ;
Forbes, Robert T. ;
Alhnan, Mohamed A. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 128 :282-289
[4]   Safety of levetiracetam among infants younger than 12 months - Results from a European multicenter observational study [J].
Arzimanoglou, Alexis ;
Loesch, Christian ;
Garate, Pablo ;
Bentz, Jurgen .
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2016, 20 (03) :368-375
[5]   Reshaping drug development using 3D printing [J].
Awad, Atheer ;
Trenfield, Sarah J. ;
Goyanes, Alvaro ;
Gaisford, Simon ;
Basit, Abdul W. .
DRUG DISCOVERY TODAY, 2018, 23 (08) :1547-1555
[6]   3D printed tablets loaded with polymeric nanocapsules: An innovative approach to produce customized drug delivery systems [J].
Beck, R. C. R. ;
Chaves, P. S. ;
Goyanes, A. ;
Vukosavljevic, B. ;
Buanz, A. ;
Windbergs, M. ;
Basit, A. W. ;
Gaisford, S. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 528 (1-2) :268-279
[7]   The influence levetiracetam on psychosocial and behavioral functioning in children: A case-control and follow-up study [J].
Bektas, Gonca ;
Tekin, Ugur ;
Ozkan, Melis Ulak ;
Yildiz, Edibe Pembegul ;
Caliskan, Mine ;
Ozmen, Meral ;
Aydinli, Nur .
EPILEPSY & BEHAVIOR, 2017, 72 :39-42
[8]   Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy [J].
Boon, P ;
Chauvel, P ;
Pohlmann-Eden, B ;
Otoul, C ;
Wroe, S .
EPILEPSY RESEARCH, 2002, 48 (1-2) :77-89
[9]   Perampanel with concomitant levetiracetam and topiramate: Post hoc analysis of adverse events related to hostility and aggression [J].
Chung, Steve ;
Williams, Betsy ;
Dobrinsky, Cindy ;
Patten, Anna ;
Yang, Haichen ;
Laurenza, Antonio .
EPILEPSY & BEHAVIOR, 2017, 75 :79-85
[10]   3D printing applications for transdermal drug delivery [J].
Economidou, Sophia N. ;
Lamprou, Dimitrios A. ;
Douroumis, Dennis .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 544 (02) :415-424